PTX Media related, page-346

Sh@tloads of cash in the bank is relative. And for a drug discovery biotech, you have to spend money to make money. If you preserve cash instead of progressing the pipeline you are reducing share holder wealth. Waste money on ill thought out trials you are reducing share holder wealth.

Only SYC and the BOD have seen the big picture. They have a pretty good track record. If they need more cash, they need more cash. Thats how this end of the market works. We have more trials on the way. We have more pre clinical on the way. So costs are going to increase. But with that cost increase comes pipeline progression. And thats the money maker.

I have no idea when the next raise will happen. I would hope SYC does. And when the time is right we find out.

Important things for the investor is to see that pipeline keep moving. To see promise the drugs are working. And ensure that the next few quartets are financed.

We get the easy job.

I am slowly converting some of my OCs just in case. Look at the news flow around the last raise. That was well done, even though lots of posters thought otherwise. That 5c raise set us up to where we are now. SYC seems to have things well under control.